The role of the Bcl-2 protein family in cancer

Leigh Coultas1, Andreas Strasser

  • 1Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Vic. 3050, Australia.

Insights

Mutations inhibiting programmed cell death (apoptosis) drive cancer. The Bcl-2 protein family plays a key role in cancer development and treatment, influencing cell death pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Programmed cell death (apoptosis) is crucial for preventing uncontrolled cell proliferation.
  • Mutations disrupting apoptosis are implicated in various cancers, including lymphomas.
  • The Bcl-2 family of proteins regulates apoptosis.

Purpose of the Study:

  • To review the molecular mechanisms controlling programmed cell death.
  • To discuss the role of Bcl-2 family proteins in cancer development.
  • To explore the implications of Bcl-2 proteins in anti-cancer therapies.

Main Methods:

  • Literature review of seminal studies and current research on Bcl-2 and apoptosis.
  • Analysis of molecular pathways regulating cell death.
  • Synthesis of findings on the role of Bcl-2 family members in tumorigenesis.

Main Results:

  • Inhibiting apoptosis through mutations, particularly involving Bcl-2, promotes cancer.
  • The balance of pro-apoptotic and anti-apoptotic Bcl-2 proteins is critical in cancer.
  • Bcl-2 family proteins affect cancer cell sensitivity to chemotherapy and radiotherapy.

Conclusions:

  • Interference with programmed cell death is a hallmark of neoplastic transformation.
  • Targeting Bcl-2 family proteins offers potential therapeutic strategies for cancer.
  • Understanding Bcl-2's role is vital for advancing cancer treatment and prevention.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...